-
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma - RNA
Dataset
EGAD50000001725
-
Cancer Genomics Lab at Johns Hopkins
Dac
EGAC00001003656
-
Pan Prostate Cancer Group Germany BAM files
Dataset
EGAD00001005997
-
DAC for Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers
Dac
EGAC50000000332
-
Prefibrotic Bone Marrow Microenvironment is a Hallmark of Clonal Hematopoiesis
Study
EGAS50000001774
-
NICHE - Pre-treatment single cell RNA-seq of MMR proficient early stage colon cancers
Dataset
EGAD50000002853
-
Pre-existing immunity and hrHPV status as determinants of immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial
Study
EGAS50000001571
-
DAC Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dac
EGAC50000000694
-
Cell-Free DNA Fragmentation Distinguish Immunotherapy Responders from Non- Responders in Head and Neck Cancer: A Multi-Institute Prospective Study
Study
EGAS50000001286
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Italian Cancer Center Data Access Committee
Dac
EGAC00001003631
-
Genetic, epigenetic and fragmentomic profiling of plasma cell-free DNA in cancer patients
Study
EGAS50000002022
-
Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution
Study
EGAS50000002011
-
Genetic, epigenetic and fragmentomic profiling of plasma cell-free DNA in cancer patients
Dataset
EGAD50000002912
-
Nicotinamide phosphoribosyltransferase is an integrator of circadian clock regulation and NAD+ metabolism in liver cancer
Study
EGAS50000000868
-
The Precision Medicine in Liver Cancer across an Asia-pacific NETwork (PLANET) – HCC recurrence cohort
Study
EGAS50000000869
-
The dataset for Genomic landscapes of endometrioid and mucinous ovarian cancers and morphologically similar tumor types
Dataset
EGAD50000000744
-
The dataset of Detection and characterization of lung cancer using cell-free DNA fragmentomes on NovaSeq 6000 at 1-2x coverage
Dataset
EGAD50000001961
-
Analysis of Somatic Mutations from Liquid Biopsy-Derived cfDNA in Advanced Cancers
Study
EGAS50000001169
-
Analysis of Somatic Mutations and Neoantigen Landscape from Liquid Biopsy-Derived cfDNA in Advanced Cancers
Dac
EGAC50000000717
-
Validation of cfDNA fragmentome analyses for early detection of liver cancer
Study
EGAS00001008111
-
Methylation data for Genomic landscapes of endometrioid and mucinous ovarian cancers and morphologically similar tumor types
Study
EGAS00001008175
-
A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity
Dataset
EGAD00001015516
-
Analysis of Somatic Mutations and Neoantigen Landscape from Liquid Biopsy-Derived cfDNA in Advanced Cancers
Dataset
EGAD50000001671
-
Exome (FrTu, cfDNA and normal), transcriptome (FrTu) and single-cell (PBLs) sequencing of metastatic cancer patients
Dataset
EGAD50000001672
-
PARADIGM: Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment
Study
EGAS50000001357
-
Clinical Outcomes of 344 Diffuse Large B-Cell Lymphoma patients
Study
EGAS50000001054
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505
-
IMMUcan SCCHN1 cohort
Study
EGAS50000001533
-
Whole-genome sequencing study of uveal melanoma
Study
EGAS50000001603
-
Evaluation Of The Role Of Tumor Mutational Burden As A Prognostic Biomarker In Follicular Lymphoma
Study
EGAS50000001448
-
MIBC NAC2020 cohort RNA sequencing
Study
EGAS50000000741
-
A New CA19-9 Cut-Off Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC
Study
EGAS50000001575
-
Patient-specific CAR T cell barriers in colorectal cancer identified by phenotypic screening of tumor organoids
Study
EGAS50000002034
-
DKTK Organoid Platform: A multicentric living biobank for functionalizing patient-derived organoids and model clinical outcomes
Study
EGAS50000002045
-
Bulk RNA Sequencing of 112 Bladder Cancer Tumor Samples Using Lexogen QuantSeq 3′ mRNA-Seq
Study
EGAS50000002032
-
Raw Bulk QuantSeq 3′ mRNA Sequencing Data from 137 Bladder Cancer Tumor Samples
Dataset
EGAD50000002920
-
Processed Gene-Level Expression Counts from 137 Bladder Cancer QuantSeq 3′ RNA-seq Samples
Dataset
EGAD50000002921
-
Clinical Annotation and Survival Metadata for 137 Bladder Cancer Samples
Dataset
EGAD50000002922
-
High grade serous ovarian cancer tumor exome sequencing
Study
EGAS50000001731
-
Whole-exome and RNA-seq sequencing of HCC of metastatic and de novo origin
Study
EGAS50000002057
-
G4SCOPE identifies sequence features and epigenetic contexts of chromatin G-quadruplexes
Study
EGAS50000002094
-
BCAC TIIC Data
Study
EGAS50000001477
-
RNA sequencing to characterize ALK
Study
EGAS50000001779
-
Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)
Study
EGAS00001007469
-
H021-Master Umbrella study2 (not to be released)
Study
EGAS00001005145
-
Cord blood DNA duplex sequencing libraries using deepDLP
Study
EGAS50000002002
-
High Grade Serous Ovarian Cancer Whole Exome Sequencing
Dataset
EGAD50000002488
-
Follicular Lymphoma Whole Genome and Transcriptome Sequencing
Study
EGAS00001006646
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
METABRIC
Study
EGAS00000000098
-
Efficacy of dual KRAS G12D–EGFR blockade versus triple combinations in patient-derived models of KRAS G12D-mutant colorectal cancer
Study
EGAS50000001700
-
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
Study
EGAS00001004469
-
IDH1 Somatic Mutation Profile in Intrahepatic Cholangiocarcinoma
Study
EGAS50000001638
-
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Study
EGAS50000000932
-
Patient-derived organoids as predictive models for drug testing and repurposing in glioblastoma therapy
Study
EGAS50000001221
-
Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups
Study
EGAS50000001964
-
Initial leukemic epigenomic state determines hypomethylating agent response
Study
EGAS50000000936
-
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
Study
EGAS00001004660
-
Mitochondrial peroxiredoxin 3 is a tractable cancer therapeutic target modulated by SLC7A11
Study
EGAS50000001827
-
RAF1 extrachromosomal DNA amplification confers acquired erlotinib resistance in NSCLC cell model
Study
EGAS50000001832
-
Single-cell profiling reveals mechanisms of response to anti-PD-L1 versus anti-PD-L1 combined with anti-CTLA4 in head and neck squamous cell carcinoma
Study
EGAS50000000037
-
Targeted capture, whole genome sequencing, and RNAseq to identify rearrangements in B-cell lymphomas
Study
EGAS50000000328
-
Uncovering the potential of circulating tumor DNA for pediatric precision oncology
Study
EGAS50000000393
-
Accelerated single cell seeding in relapsed multiple myeloma
Study
EGAS00001004404
-
Anti-Cancer Therapies Induce Mutations in Adult Stem Cells in a Tissue-Specific Manner
Study
EGAS00001006042
-
High-depth whole genome sequencing of 51 premalignant breast lesions
Study
EGAS50000001436
-
DCIS fresh frozen fragmentomics dataset
Study
EGAS50000001475
-
High-depth whole genome sequencing of 26 premalignant breast lesions
Study
EGAS50000001559
-
A mathematical model of cell-free DNA fragment size reveals cancer-specific fragmentomic patterns
Study
EGAS50000001560
-
Neo-CheckRay
Study
EGAS50000001777
-
Spatial predictors of response to immunotherapy in microsatellite stable metastatic colorectal cancer
Study
EGAS50000001567
-
Tremelimumab +/- durvalumab in combination with paclitaxel as immune induction in metastatic urothelial cancer: clinical and translational results of the ICRA trial
Study
EGAS50000001574
-
HSC_population_dynamics_KSP_samples
Study
EGAS00001002762
-
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Study
EGAS50000000607
-
Dynamics of tumor ecosystems and microbiome in response to neoadjuvant atezolizumab, bevacizumab, and FOLFOX treatment in patients with unresectable colorectal cancer with liver metastasis
Study
EGAS50000000677
-
Spatial Transcriptomics Uncovers Tumor Microenvironment-Based Subtypes in Invasive Lobular Carcinoma
Study
EGAS50000001001
-
Clonal evolution of metastatic colorectal cancer under anticancer therapies
Study
EGAS50000001023
-
Gene expression adaptation of metastases to their host tissue
Study
EGAS50000000817
-
Copy number profiling of circulating cell-free DNA from high grade serous ovarian cancer patients
Study
EGAS00001004670
-
Human PMS1-dependent non-canonical mismatch repair converges with MBD4 to repair 5-methylcytosine deamination
Study
EGAS50000001662
-
Screening for Prostate Cancer-Specific Differentially Methylated Regions Based on MeDIP-seq
Study
EGAS50000001894
-
Intrapatient tumor heterogeneity and clonal evolution in metastatic salivary gland cancer: an autopsy study
Study
EGAS50000001420
-
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes
Study
EGAS50000000536
-
TransNEO neoadjuvant breast cancer study
Study
EGAS00001004582
-
Fragmentation signatures in cancer patients are similar to those in patients with vascular and autoimmune diseases
Study
EGAS00001008004
-
ProstOmics: spatial and bulk multi-omics of prostate cancer
Study
EGAS50000000413
-
an integrated molecular study of clear cell renal cell carcinoma (ccRCC) including whole-genome/exome and RNA sequencing as well as array-based gene expression/copy-number/methylation analyses
Study
EGAS00001000509
-
Cell-free DNA fragmentome profiles predict immunotherapy response
Study
EGAS50000001837
-
Ouro-seq: Improved Recovery of Full-Length circRNAs from Samples with Limited RNA Content Using Short-Amplicon Suppression
Study
EGAS50000001356
-
High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage
Study
EGAS50000001910
-
Arcagen - Gynecologic cancer domain
Study
EGAS50000000900
-
Circulating cell-free DNA methylation profiling for detection, distinction, and estrogen receptor status classification of advanced breast cancer
Study
EGAS50000001675
-
Whole Exome Sequencing and RNA Sequencing data
Dataset
EGAD50000002962
-
Serafini et al., Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer
Study
EGAS50000001968
-
Fragmentomics Uncover Non-Mutational HRD Features
Study
EGAS00001008190
-
A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer
Study
EGAS50000002061
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469
-
Whole-exome sequencing and RNA-seq data of paired normal-tumour samples from MMR-proficient early-onset colorectal cancer patients
Study
EGAS50000001296
-
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000001760
-
SCANDARE TNBC
Study
EGAS50000000970